These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11296371)

  • 1. [Increase in serum creatine phosphokinase following administration of talipexole hydrochloride].
    Osumi E; Imai T
    Rinsho Shinkeigaku; 2000 Oct; 40(10):1041-3. PubMed ID: 11296371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sinus bradycardia induced by talipexole hydrochloride in a patient with Parkinson disease].
    Sakai T; Ii Y; Kuzuhara S
    Rinsho Shinkeigaku; 1998 Aug; 38(8):771-5. PubMed ID: 9916527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
    Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
    Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case].
    Ichiba T; Takemoto N
    Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant neuroleptic syndrome--a possibility for early diagnosis].
    Rasmussen KT; Scherling A
    Ugeskr Laeger; 1991 Oct; 153(43):3018-9. PubMed ID: 1801391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
    Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
    Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of serum myosin light chain-1 level in neuroleptic malignant syndrome].
    Konagaya M; Iida M; Konagaya Y
    No To Shinkei; 1994 Apr; 46(4):373-8. PubMed ID: 8024837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine treatment of neuroleptic malignant syndrome.
    Dhib-Jalbut S; Hesselbrock R; Mouradian MM; Means ED
    J Clin Psychiatry; 1987 Feb; 48(2):69-73. PubMed ID: 3804991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of malignant syndrome associated with a parkinsonism patient.
    Sanga M; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute dopamine deficiency and malignant neuroleptic-like syndrome].
    Ezrielev GZ
    Harefuah; 1992 Apr; 122(8):503-5, 551. PubMed ID: 1398317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome in a patient with polyneuropathy: mechanism of muscle rigidity and elevated serum creatine kinase levels].
    Takashima S; Hirade S; Taguchi Y; Inoue H
    Rinsho Shinkeigaku; 1998; 38(10-11):955-7. PubMed ID: 10203983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
    Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T
    Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All elevated creatine kinase is not neuroleptic malignant syndrome.
    Maniam T; Rahman MA
    Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
    Kumagai R; Harada T; Kurokawa K; Okazaki M; Egi N; Shimote K; Nakamura S
    No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome].
    Chodorowski Z; Anand JS; Rutkowski P
    Przegl Lek; 2003; 60(4):299-301. PubMed ID: 14569909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of a patient with neuroleptic malignant syndrome associated with marked elevation of serum creatine kinase.
    Takizawa D; Nishikawa K; Hiraoka H; Hinohara H; Saito S; Goto F; Kunimoto F
    J Anesth; 2004; 18(2):135-7. PubMed ID: 15127263
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.